600594 logo

Guizhou Yibai Pharmaceutical Co., Ltd. Stock Price

SHSE:600594 Community·CN¥3.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600594 Share Price Performance

CN¥3.99
0.31 (8.42%)
CN¥3.99
0.31 (8.42%)
Price CN¥3.99

600594 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

1 Risk
0 Rewards

Guizhou Yibai Pharmaceutical Co., Ltd. Key Details

CN¥1.9b

Revenue

CN¥778.2m

Cost of Revenue

CN¥1.1b

Gross Profit

CN¥1.4b

Other Expenses

-CN¥234.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 23, 2026
-0.30
59.19%
-12.30%
33.6%
View Full Analysis

About 600594

Founded
1995
Employees
5261
CEO
Ya Qi Dou
WebsiteView website
www.gzcci.com

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investment in the cultivation and breeding projects of medicinal materials; and agricultural products sale, as well as provides market information consulting services for medicinal materials. In addition, it is involved in the research and development, and information consulting services for health food. The company was founded in 1995 and is based in Guiyang, China.

Recent 600594 News & Updates

Recent updates

No updates